| 51 |
28353223 | Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease. | 2017 |
1 |
| 52 |
28521765 | Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice. | 2017 May 18 |
1 |
| 53 |
28866979 | Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome. | 2017 Sep 4 |
1 |
| 54 |
25465240 | Olfactory Deprivation Hastens Alzheimer-Like Pathologies in a Human Tau-Overexpressed Mouse Model via Activation of cdk5. | 2016 Jan |
2 |
| 55 |
26253588 | Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease. | 2016 Oct |
1 |
| 56 |
26836182 | Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. | 2016 |
1 |
| 57 |
26890756 | The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease. | 2016 |
1 |
| 58 |
27073990 | DYRK1A inhibition as potential treatment for Alzheimer's disease. | 2016 Apr |
1 |
| 59 |
27276722 | [Cerebrospinal fluid biomarkers of Alzheimer's disease in current clinical practice]. | 2016 Apr 20 |
2 |
| 60 |
27280380 | Gramine Derivatives Targeting Ca(2+) Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases. | 2016 Jul 14 |
1 |
| 61 |
27296778 | Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. | 2016 Aug |
1 |
| 62 |
25467137 | Configuration-specific immunotherapy targeting cis pThr231-Pro232 tau for Alzheimer disease. | 2015 Jan 15 |
3 |
| 63 |
25659857 | Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease. | 2015 Mar |
2 |
| 64 |
25707998 | Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis. | 2015 May |
1 |
| 65 |
26366630 | Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease. | 2015 Nov |
1 |
| 66 |
26402072 | Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds. | 2015 |
2 |
| 67 |
23969178 | Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly. | 2014 Jan |
2 |
| 68 |
24033439 | Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome. | 2014 Feb |
1 |
| 69 |
24378367 | The role of clusterin in amyloid-β-associated neurodegeneration. | 2014 Feb |
1 |
| 70 |
24444746 | O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers. | 2014 Apr 17 |
1 |
| 71 |
24492862 | Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis. | 2014 Apr |
1 |
| 72 |
24548642 | Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid. | 2014 May 1 |
1 |
| 73 |
22710920 | Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. | 2013 |
1 |
| 74 |
23362255 | Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites. | 2013 Mar 15 |
2 |
| 75 |
23430246 | β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models. | 2013 Apr 12 |
3 |
| 76 |
21741127 | Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers. | 2012 Aug |
1 |
| 77 |
21945393 | Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models. | 2012 Jan |
2 |
| 78 |
22057275 | Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. | 2012 Feb 3 |
1 |
| 79 |
22153704 | [Multicenter study on lumbar puncture indication, clinical practice and feasibility]. | 2012 Jan |
2 |
| 80 |
22332192 | Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. | 2012 Feb |
2 |
| 81 |
22334661 | Synaptic released zinc promotes tau hyperphosphorylation by inhibition of protein phosphatase 2A (PP2A). | 2012 Mar 30 |
2 |
| 82 |
22367557 | Roles of AMP-activated protein kinase in Alzheimer's disease. | 2012 Mar |
1 |
| 83 |
20706749 | Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody. | 2011 Mar |
1 |
| 84 |
21056617 | Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease. | 2011 Jan |
2 |
| 85 |
21220682 | Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. | 2011 Jan |
1 |
| 86 |
21573099 | β-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites. | 2011 May 6 |
1 |
| 87 |
21671254 | Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes. | 2011 Sep |
1 |
| 88 |
18692273 | Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study. | 2010 May |
2 |
| 89 |
19853650 | Total and phosphorylated tau protein as biological markers of Alzheimer's disease. | 2010 Jan |
1 |
| 90 |
20110615 | Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg. | 2010 |
1 |
| 91 |
20186703 | Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease. | 2010 Apr |
1 |
| 92 |
20472896 | Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. | 2010 Jul |
1 |
| 93 |
20609109 | Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy. | 2010 Oct |
1 |
| 94 |
20862329 | SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. | 2010 Sep 16 |
1 |
| 95 |
21084733 | Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEε4 genotype. | 2010 |
1 |
| 96 |
19046355 | Tau phosphorylation at threonine-175 leads to fibril formation and enhanced cell death: implications for amyotrophic lateral sclerosis with cognitive impairment. | 2009 Feb |
1 |
| 97 |
19146641 | CSF biomarker profile and diagnostic value in vascular dementia. | 2009 Feb |
1 |
| 98 |
19307538 | CSF biomarkers in relationship to cognitive profiles in Alzheimer disease. | 2009 Mar 24 |
2 |
| 99 |
19524111 | Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P). | 2009 Sep |
1 |
| 100 |
19623258 | The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. | 2009 Jul 22 |
1 |